Cheryl Guttman Krader, BS, Pharm

An international panel of experts discussed needs and challenges in the field.

Physician offers patient counseling pearls for selected retinal diseases.

Baseline diabetic retinopathy severity is an important predictor of its progression in patients.

Investigators find that nanoparticles deliver gene therapy successfully in mice, rats.

Candidate continues to demonstrate encouraging safety, tolerability, and efficacy

Research aiming to elucidate the underlying factors for oxidative damage to the trabecular meshwork in glaucoma has led to studies of alterations in gene expression that may ultimately guide the development of genetic therapy for glaucoma, said Carla J. Siegfried, MD, recipient of the 2018 Shaffer Prize for Innovative Glaucoma Research.